October 21, 2015
Santen Vice President Sadatoshi Furukado Santen Pharmaceutical transferred its anti-rheumatic pharmaceutical business to Ayumi Pharmaceutical in August. This business generated annual sales of around 10 billion yen and operating profit of about 5 billion yen for the company. Despite a...read more